Vi · 1 day ago
Senior Recruiter
Vi is seeking a Senior Recruiter who will be responsible for driving full-cycle recruiting across various roles including enterprise go-to-market, technical, and G&A positions. The role requires a hands-on individual contributor who excels at evaluating talent and partnering with executives in a fast-paced environment.
Artificial Intelligence (AI)FitnessHealth CareInformation TechnologyLife SciencePharmaceuticalSoftwareWeb DevelopmentWellness
Responsibilities
Source and assess top enterprise GTM talent (senior sellers, enterprise sales leaders, AM)
Source and evaluate technical talent including software engineers, AI/ML, and product roles
Build creative outbound strategies using LinkedIn, Boolean search, communities, and referrals
Run fast, efficient, and high-signal search processes with strong judgment and alignment
Screen candidates efficiently while maintaining extremely high talent standards
Communicate clearly and concisely with candidates and stakeholders
Drive a high-velocity recruiting engine with strong weekly funnel performance
Partner with hiring managers to refine role definitions and expectations
Collaborate with People, Finance, and Leadership on headcount planning and process improvements
Contribute to employer brand initiatives, messaging consistency, and candidate experience design
Qualification
Required
5+ years of full-cycle recruiting experience, preferably in fast‑growing Seed through Series B startups
Strong track record sourcing and closing enterprise GTM talent
Experience recruiting technical roles (engineering, AI/ML, product)
High‑judgment talent evaluator; able to distinguish A‑players quickly and consistently
Thrives in a hands‑on IC role with high autonomy and fast pace
Exceptional communication skills—concise, high‑signal, and executive‑ready
Proven ability to operate scrappily, independently, and with urgency
Company
Vi
The enterprise AI platform powering health Vi has already helped 190M+ people live healthier lives, generated $2B+ in enterprise ROI, and accelerated development of 50+ world-changing drugs.
Funding
Current Stage
Growth StageTotal Funding
$147MKey Investors
General AtlanticSquare Peg Capital
2024-06-28Undisclosed· $111M
2018-01-03Series A· $20M
2016-06-05Product Crowdfunding· $0M
Recent News
Company data provided by crunchbase